MedTrace Logo

Zinc Sulphate vs. Zinc Amino Acid Chelate

NCT01791608 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2013-02-15

No results posted yet for this study

Summary

Acute respiratory infection and acute diarrhea are among the most prevalent diseases of childhood increase the burden of morbidity and mortality in children under 5 years.

Among the possible strategies for its prevention is important to count on good nutritional status for use in developing a good immune response to infections. Zinc deficiency has been shown to favor the development of infections and has been considered a real public health problem.

Within the zinc compounds used are zinc amino acid chelate and zinc sulphate, the first that has shown evidence of being better absorbed and tolerated.

We propose a study showing the effectiveness of zinc amino acid chelate and zinc sulphate in the prevention of acute diarrheal disease and acute respiratory infection.

Conditions

Interventions

DIETARY_SUPPLEMENT

Zinc sulfate as dietary supplementation

Zinc sulfate as dietary supplementation

DIETARY_SUPPLEMENT

Zinc amino acid chelate as dietary supplementation

Zinc amino acid chelate as dietary supplementation

DIETARY_SUPPLEMENT

Milk without fortification without zinc

Milk without fortification

Sponsors & Collaborators

  • Nutreva S.A.S.

    collaborator UNKNOWN

  • Foundation Child Care - FAN

    collaborator OTHER

  • CES University

    lead OTHER

Principal Investigators

  • Liliana LM Montoya, Master · CES University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-07-31
Completion
2012-11-30

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01791608 on ClinicalTrials.gov